Fig. 6. Performance of the MGA to enable or enhance locomotor control after stroke. Performance of the MGA to enable or enhance locomotor control after.

Slides:

Advertisements

Similar presentations

Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression. CSF1 is increased in blood of melanoma patients and correlates.

Advertisements

Fig. 1. TP is highly expressed in myeloma.

Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.

Fig. 7. Gradient of adipocyte size and FAI around the human coronaries in the presence or absence of coronary atherosclerosis. Gradient of adipocyte size.

Fig. 4. BET bromodomain inhibition suppresses transactivation of shared transcriptional networks across HF models. BET bromodomain inhibition suppresses.

Fig. 3. Design of the MGA algorithm.

Fig. 2. Interaction between upward and forward forces during standing and walking. Interaction between upward and forward forces during standing and walking.

Fig. 3 Urinary LAM concentration predicted pulmonary TB and correlated to mycobacterial burden and weight loss. Urinary LAM concentration predicted pulmonary.

Fig. 3. Structure of ALS-associated RNA binding proteins.

Effects of highly concentrated SFN provided as BSE in T2D patients

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans.

Fig. 4. Validation of MGA algorithm in individuals with SCI or stroke.

Fig. 2. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral blood. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral.

Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.

Fig. 1. Associations between fecal amino acids and their derivatives with disease in pediatric patients with Crohn’s disease compared to healthy subjects.

Fig. 4. Biomechanical properties of treated tibiae.

Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.

Fig. 1 Crohn’s disease association within the LRRK2 locus.

Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Fig. 1. Bacterial communities shift during AD disease progression.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Bio-AMS enhances the activity of rifampicin and ethambutol in vitro

Expression of CD36 and psap in a TMA of human ovarian cancer patients

Increased ADMA in pregnancy is associated with SGA birth outcomes

Fig. 6. Effects of CD31-NP targeting in perfused human kidneys.

Fig. 4. Specific versus nonspecific NP accumulation.

Fig. 4. In vivo analysis of slpA mutant in the Syrian Golden hamster.

Fig. 5. Vascularization of human liver seed grafts.

Fig. 4. Geographic atrophy progression in CFI risk-allele carriers and risk-negative subpopulations after monthly lampalizumab treatment. Geographic atrophy.

Fig. 1. IS mediates a hyperthrombotic uremic phenotype in an AHR-dependent manner across CKD stages. IS mediates a hyperthrombotic uremic phenotype in.

Fig. 5. Remnants of PS+ platelets induce neutrophil macroaggregation.

Fig. 5. In vivo characterization of adipogenesis by CT.

Fig. 2. Rheological characterization and hydrogel differentiation.

Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.

Fig. 1. Muscles of LAMA2 MD patients and dyW/dyW mice contain high amounts of laminin-α4 and show deficits in BM. Muscles of LAMA2 MD patients and dyW/dyW.

Fig. 6 pDCs infiltrate the skin of BLM-treated mice, and their depletion attenuates skin fibrosis. pDCs infiltrate the skin of BLM-treated mice, and their.

Fig. 7 Human study design for device testing.

Fig. 7. Gait training session overground with MGA or on a treadmill with upward support. Gait training session overground with MGA or on a treadmill with.

Fig. 1. Neurobehavioral testing in YG8R mice transplanted with wild-type mouse HSPCs. Neurobehavioral testing in YG8R mice transplanted with wild-type.

Fig. 3. The effects of DCA on hemodynamic and functional end points and their association with genetic factors (variants of the SIRT3 and UCP2 genes) that.

Fig. 2. SSFO or SwiChR++ modulation of mPFC neurons and rescue of social behavior deficits in CNTNAP2 KO mice. SSFO or SwiChR++ modulation of mPFC neurons.

Fig. 1. Map showing the study catchment area in the East of England.

Fig. 4. Analysis of T cell responses according to treatment and in peptide-treated C-peptide responders and nonresponders. Analysis of T cell responses.

Fig. 3. Differential mPFC PV neuron activity during exploratory behaviors in CNTNAP2 KO and WT mice. Differential mPFC PV neuron activity during exploratory.

Fig. 4. Improved tumor response to docetaxel in TNBC and trastuzumab in HER2-amplified PDX models with the addition of S Improved tumor response.

Fig. 3 Rank stability of final models.

Fig. 2. IONP characterization.

Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.

Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.

Fig. 4. Acute lung injury in miR-223−/y mice.

Fig. 3 CSF1 is expressed in human melanoma.

Fig. 7 Analysis of the bacterial nidus within tissue abscesses by MALDI IMS demonstrates a paucity of calprotectin signal. Analysis of the bacterial nidus.

Fig. 7 Vaccine-induced influenza-specific B cells are not maintained in peripheral blood. Vaccine-induced influenza-specific B cells are not maintained.

Vaccination induces activation of cTFH cells and transient ASCs

IIV induces CD21hiCD27+ and CD21loCD27+ influenza-specific B cells

Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.

Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.

Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.

Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital.

Fig. 2. BET inhibition enhances PARPi-induced DNA damage.

Fig. 1 Device structure, typical output performance, and cytocompatibility of BD-TENG. Device structure, typical output performance, and cytocompatibility.

Fig. 2. CD treatment facilitates regression of murine atherosclerosis.

Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.

Technological framework of the multidirectional gravity-assist

Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.

Fig. 1. Initial views of the 2 new browsing software packages

Fig. 3. Association between peak CTL019 expansion and response.

Presentation transcript:

Fig. 6. Performance of the MGA to enable or enhance locomotor control after stroke. Performance of the MGA to enable or enhance locomotor control after stroke. (A) Subjects with stroke walked overground without and with MGA using the least-assistive device possible. To quantify locomotor performance and identify the most relevant parameters, a PCA-based method has been applied, as described in fig. S3. On the right, the computed parameters that strongly correlated with a given PCA (|loading factors| > 0.5) were regrouped into functional clusters. Numbers refer to table S1. (B) Subjects were segregated into three categories: nonambulatory (wheelchair), crutches, and none. Images and stick diagram decomposition of whole-body movements (and assistive device) are shown for each category and condition. (C) Plots reporting the mean values of locomotor performance and classic gait parameters for each subject during locomotion without and with MGA. In addition, a symmetry index reports the relative symmetry between left and right step lengths for each subject. The mean (horizontal orange bar) ± SEM (thickness) measured during locomotion in healthy subjects is represented. *P < 0.05, Wilcoxon signed-rank tests, n = 12 subjects with stroke. Jean-Baptiste Mignardot et al., Sci Transl Med 2017;9:eaah3621 Published by AAAS